Abstract
Mutation and selection are the essential steps of evolution. Researchers have long used in vitro mutagenesis, expression, and selection techniques in laboratory bacteria and yeast cultures to evolve proteins with new properties, termed directed evolution. Unfortunately, the nature of mammalian cells makes applying these mutagenesis and whole-organism evolution techniques to mammalian protein expression systems laborious and time consuming. Mammalian evolution systems would be useful to test unique mammalian cell proteins and protein characteristics, such as complex glycosylation. Protein evolution in mammalian cells would allow for generation of novel diagnostic tools and designer polypeptides that can only be tested in a mammalian expression system. Recent advances have shown that mammalian cells of the immune system can be utilized to evolve transgenes during their natural mutagenesis processes, thus creating proteins with unique properties, such as fluorescence. On a more global level, researchers have shown that mutation systems that affect the entire genome of a mammalian cell can give rise to cells with unique phenotypes suitable for commercial processes. This review examines the advances in mammalian cell and protein evolution and the application of this work toward advances in commercial mammalian cell biotechnology.
Similar content being viewed by others
References
Wang, T. W., Zhu, H., Ma, X. Y., Zhang, T., Ma, Y. S., & Wei, D. Z. (2006). Mutant library construction in directed molecular evolution: casting a wider net. Molecular Biotechnology, 34, 55–68. doi:10.1385/MB:34:1:55.
Lutz, S., & Patrick, W. M. (2004). Novel methods for directed evolution of enzymes: quality, not quantity. Current Opinion in Biotechnology, 15, 291–297. doi:10.1016/j.copbio.2004.05.004.
Arakawa, H., Kudo, H., Batrak, V., Caldwell, R. B., Rieger, M. A., Ellwart, J. W., et al. (2008). Protein evolution by hypermutation and selection in the B cell line DT40. Nucleic Acids Research, 36, e1. doi:10.1093/nar/gkm616.
Wurm, F. M. (2004). Production of recombinant protein therapeutics in cultivated mammalian cells. Nature Biotechnology, 22, 1393–1398. doi:10.1038/nbt1026.
Matsuura, T., & Yomo, T. (2006). In vitro evolution of proteins. Journal of Bioscience and Bioengineering, 101, 449–456. doi:10.1263/jbb.101.449.
Orencia, M. C., Yoon, J. S., Ness, J. E., Stemmer, W. P., & Stevens, R. C. (2001). Predicting the emergence of antibiotic resistance by directed evolution and structural analysis. Nature Structural Biology, 8, 238–242. doi:10.1038/84981.
Stefan, A., Radeghieri, A., Gonzalez Vara y Rodriguez, A., & Hochkoeppler, A. (2001). Directed evolution of beta-galactosidase from Escherichia coli by mutator strains defective in the 3’– > 5’ exonuclease activity of DNA polymerase III. FEBS Letters, 493, 139–143. doi:10.1016/S0014-5793(01)02293-1.
Aharoni, A., Gaidukov, L., Yagur, S., Toker, L., Silman, I., & Tawfik, D. S. (2004). Directed evolution of mammalian paraoxonases PON1 and PON3 for bacterial expression and catalytic specialization. Proceedings of the National Academy of Sciences of the United States of America, 101, 482–487. doi:10.1073/pnas.2536901100.
Kumar, S., Chen, C. S., Waxman, D. J., & Halpert, J. R. (2005). Directed evolution of mammalian cytochrome P450 2B1: mutations outside of the active site enhance the metabolism of several substrates, including the anticancer prodrugs cyclophosphamide and ifosfamide. The Journal of Biological Chemistry, 280, 19569–19575. doi:10.1074/jbc.M500158200.
Kwaks, T. H., & Otte, A. P. (2006). Employing epigenetics to augment the expression of therapeutic proteins in mammalian cells. Trends in Biotechnology, 24, 137–142. doi:10.1016/j.tibtech.2006.01.007.
Wang, C. L., Yang, D. C., & Wabl, M. (2004). Directed molecular evolution by somatic hypermutation. Protein Engineering, Design & Selection, 17, 659–664. doi:10.1093/protein/gzh080.
Wang, L., Jackson, W. C., Steinbach, P. A., & Tsien, R. Y. (2004). Evolution of new nonantibody proteins via iterative somatic hypermutation. Proceedings of the National Academy of Sciences of the United States of America, 101, 16745–16749. doi:10.1073/pnas.0407752101.
Yang, N., & Kazazian, H. H., Jr. (2006). L1 retrotransposition is suppressed by endogenously encoded small interfering RNAs in human cultured cells. Nature Structural & Molecular Biology, 13, 763–771. doi:10.1038/nsmb1141.
Rajewsky, K., Forster, I., & Cumano, A. (1987). Evolutionary and somatic selection of the antibody repertoire in the mouse. Science, 238, 1088–1094. doi:10.1126/science.3317826.
Li, Z., Woo, C. J., Iglesias-Ussel, M. D., Ronai, D., & Scharff, M. D. (2004). The generation of antibody diversity through somatic hypermutation and class switch recombination. Genes & Development, 18, 1–11. doi:10.1101/gad.1161904.
Peled, J. U., Kuang, F. L., Iglesias-Ussel, M. D., Roa, S., Kalis, S. L., Goodman, M. F., et al. (2008). The Biochemistry of Somatic Hypermutation. Annual Review of Immunology, 26, 481–511. doi:10.1146/annurev.immunol.26.021607.090236.
Martin, A., & Scharff, M. D. (2002). AID and mismatch repair in antibody diversification. Nature Reviews. Immunology, 2, 605–614. doi:10.1038/nri799.
Cumbers, S. J., Williams, G. T., Davies, S. L., Grenfell, R. L., Takeda, S., Batista, F. D., et al. (2002). Generation and iterative affinity maturation of antibodies in vitro using hypermutating B-cell lines. Nature Biotechnology, 20, 1129–1134. doi:10.1038/nbt752.
Bachl, J., Carlson, C., Gray-Schopfer, V., Dessing, M., & Olsson, C. (2001). Increased transcription levels induce higher mutation rates in a hypermutating cell line. Journal of Immunology (Baltimore, MD: 1950), 166, 5051–5057.
Storb, U., Peters, A., Klotz, E., Kim, N., Shen, H. M., Hackett, J., et al. (1998). Cis-acting sequences that affect somatic hypermutation of Ig genes. Immunological Reviews, 162, 153–160. doi:10.1111/j.1600-065X.1998.tb01424.x.
Wang, L., & Tsien, R. Y. (2006). Evolving proteins in mammalian cells using somatic hypermutation. Nature Protocols, 1, 1346–1350. doi:10.1038/nprot.2006.243.
Kanayama, N., Todo, K., Takahashi, S., Magari, M., & Ohmori, H. (2006). Genetic manipulation of an exogenous non-immunoglobulin protein by gene conversion machinery in a chicken B cell line. Nucleic Acids Research, 34, e10. doi:10.1093/nar/gnj013.
Yomano, L. P., York, S. W., & Ingram, L. O. (1998). Isolation and characterization of ethanol-tolerant mutants of Escherichia coli KO11 for fuel ethanol production. Journal of Industrial Microbiology & Biotechnology, 20, 132–138. doi:10.1038/sj.jim.2900496.
Keating, J. D., Panganiban, C., & Mansfield, S. D. (2006). Tolerance and adaptation of ethanologenic yeasts to lignocellulosic inhibitory compounds. Biotechnology and Bioengineering, 93, 1196–1206. doi:10.1002/bit.20838.
Matsumura, M., Shimoda, M., Arii, T., & Kataoka, H. (1991). Adaptation of hybridoma cells to higher ammonia concentration. Cytotechnology, 7, 103–112.
Prentice, H. L., Ehrenfels, B. N., & Sisk, W. P. (2007). Improving Performance of Mammalian Cells in Fed-Batch Processes through “Bioreactor Evolution”. Biotechnology Progress, 23, 458–464.
al-Rubeai, M., & Singh, R. P. (1998). Apoptosis in cell culture. Current Opinion in Biotechnology, 9, 152–156. doi:10.1016/S0958-1669(98)80108-0.
Perani, A., Singh, R. P., Chauhan, R., & Al-Rubeai, M. (1998). Variable functions of bcl-2 in mediating bioreactor stress- induced apoptosis in hybridoma cells. Cytotechnology, 28, 12. doi:10.1023/A:1008002319400.
Sonna, L. A., Fujita, J., Gaffin, S. L., & Lilly, C. M. (2002). Invited review: Effects of heat and cold stress on mammalian gene expression. J Appl Physiol, 92, 1725–1742.
Chu, E. H. (1983). Mutation systems in cultured mammalian cells. Annals of the New York Academy of Sciences, 407, 221–230. doi:10.1111/j.1749-6632.1983.tb47827.x.
Carabeo, R. A., & Hackstadt, T. (2001). Isolation and characterization of a mutant Chinese hamster ovary cell line that is resistant to Chlamydia trachomatis infection at a novel step in the attachment process. Infection and Immunity, 69, 5899–5904. doi:10.1128/IAI.69.9.5899-5904.2001.
Urlaub, G., & Chasin, L. A. (1980). Isolation of Chinese hamster cell mutants deficient in dihydrofolate reductase activity. Proceedings of the National Academy of Sciences of the United States of America, 77, 4216–4220. doi:10.1073/pnas.77.7.4216.
Chiang, G. G., & Sisk, W. P. (2005). Bcl-x(L) mediates increased production of humanized monoclonal antibodies in Chinese hamster ovary cells. Biotechnology and Bioengineering, 91, 779–792. doi:10.1002/bit.20551.
Nicolaides, N. C., Ebel, W., Kline, B., Chao, Q., Routhier, E., Sass, P. M., et al. (2005). Morphogenics as a tool for target discovery and drug development. Annals of the New York Academy of Sciences, 1059, 86–96. doi:10.1196/annals.1339.029.
Radha, S., & Natarajan, A. T. (1998). Sodium arsenite-induced chromosomal aberrations in the Xq arm of Chinese hamster cell lines. Mutagenesis, 13, 229–234. doi:10.1093/mutage/13.3.229.
Aebi, S., Kurdi-Haidar, B., Gordon, R., Cenni, B., Zheng, H., Fink, D., et al. (1996). Loss of DNA mismatch repair in acquired resistance to cisplatin. Cancer Research, 56, 3087–3090.
Nicolaides, N. C., Littman, S. J., Modrich, P., Kinzler, K. W., & Vogelstein, B. (1998). A naturally occurring hPMS2 mutation can confer a dominant negative mutator phenotype. Molecular and Cellular Biology, 18, 1635–1641.
Grasso, L., Kline, J., Chao, Q., Routhier, E., Ebel, W., Sass, P. M., et al. (2004). Enhancing Therapeutic Antibodies and Titer Yields of Mammalian Cell Lines. BioProcess International, 2, 58–64.
Chapman, S., Oparka, K. J., & Roberts, A. G. (2005). New tools for in vivo fluorescence tagging. Current Opinion in Plant Biology, 8, 565–573. doi:10.1016/j.pbi.2005.09.011.
Loening, A. M., Wu, A. M., & Gambhir, S. S. (2007). Red-shifted Renilla reniformis luciferase variants for imaging in living subjects. Nature Methods, 4, 641–643. doi:10.1038/nmeth1070.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Majors, B.S., Chiang, G.G. & Betenbaugh, M.J. Protein and Genome Evolution in Mammalian Cells for Biotechnology Applications. Mol Biotechnol 42, 216–223 (2009). https://doi.org/10.1007/s12033-009-9156-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12033-009-9156-x